New Drug Combo Improves Skin Cancer Survival, CAR T Therapy Shrinks Brain Tumors, FDA Approves Moderna's mNEXSPIKE Vaccine, Vepdegestrant Doubles Survival in Trials, and more...

(0:10): New Drug Combo Boosts Survival in Advanced Skin Cancer, Promising Future Treatment Shift(2:20): Promising Dual-Target CAR T Therapy Shrinks Tumors in Aggressive Brain Cancer, Extends Survival(4:30): FDA Approves Moderna's mNEXSPIKE for High-Risk Groups, Shifts Vaccine Strategy(7:00): New Drug Vepdegestrant Doubles Progression-Free Survival in Breast Cancer Trial(9:45): Revolutionary Infrared Contact Lenses Let Humans See in the DarkTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: MedpageToday